Paraoxonase-1 Is Not a Major Determinant of Stent Thrombosis in a Taiwanese Population-Reference-Cited by-同舟云学术

Paraoxonase-1 Is Not a Major Determinant of Stent Thrombosis in a Taiwanese Population

Published:2012-06-18 Issue:6 Volume:7 Page:e39178
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Chen Dong-Yi,Wang Chao-Yung,Wen Ming-Shien,Lee Tsong-Hai,Chu Yen,Hsieh Ming-Jer,Chang Shang-Hung,Lee Cheng-Hung,Wang Jian-Liang,Chen Chun-Chi,Lu Laing-Suei,Lee Ming-Ta,Yeh San-Jou,Lin Fun-Chiung,Hsieh I-Chang

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee.;Circulation,2008

2. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.;S Yusuf;N Engl J Med,2001

3. Clopidogrel response variability and future therapies: clopidogrel: does one size fit all?;M O’Donoghue;Circulation,2006

4. Variability in platelet responsiveness to clopidogrel among 544 individuals.;VL Serebruany;J Am Coll Cardiol,2005

5. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity.;PA Gurbel;Circulation,2003

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of CYP2C19 Genotype on the Platelet Reactivity Index (PRI) among Chronic Coronary Syndromes (CCS) Patients Undergoing Percutaneous Coronary Intervention (PCI): Affectability of Rapid Genetic Testing;Cardiovascular Drugs and Therapy;2024-01-15

2. Advances and Perspectives in methods for identifying high platelet reactivity;Heliyon;2023-12

3. Association between Q192R PON1 genetic polymorphism and major adverse cardiovascular events in patients treated with clopidogrel: an updated meta-analysis;Expert Opinion on Drug Safety;2023-05-08

4. Multiple genetic mutations increase the risk of thrombosis associated with clopidogrel after percutaneous coronary intervention;Pharmacogenomics;2023-03

5. Investigation of dual antiplatelet therapy after coronary stenting in patients with chronic kidney disease;PLOS ONE;2021-08-04